Navigation Links
Acceliant Participates as Platinum Sponsor at the SCDM Annual Conference in Los Angeles
Date:9/18/2012

LOS ANGELES and HERNDON, Virginia, September 18, 2012 /PRNewswire/ --

Acceliant is expanding the boundaries of eClinical trial technologies by delivering an end-to end clinical trial solution integrating Electronic Data Capture (EDC) and Patient Reported Outcomes (e-PRO) to support various clinical development activities in the life sciences industry. At the SCDM 2012 Annual Conference, held in Los Angeles Sep. 22-25, Acceliant, a Platinum sponsor, will showcase "Integration of e-PRO through multi-modal data capture with the power of EDC."

A product demonstration is slated for September 24 at 7:15 a.m. in the Platinum Ballroom, Salons I-JW Marriott Live Hotel. Join us for hands-on experience on the technology in this session. Acceliant also invites all conference attendees to visit Booth #200 where Acceliant will showcase the integration of several new EDC and e-PRO modules.

Ven Thangaraj, CTO of Acceliant said, "Globally, Clinical Data Management Practice takes advantage of new data gathering technologies and processes to improve the speed and quality of data collection and rapidly merge it with EDC systems. Acceliant has developed a single EDC/e-PRO system that offers a superior solution by allowing study data to be readily available, eliminating integration costs. Acceliant will also showcase several of its proprietary solutions on the SCDM platform for pharmaceutical, biotech, and CROs who spend considerable time and money in the selection process."

Sri Manchala, CEO and President of Acceliant said, "The SCDM Annual Conference is an important event attended by clinical professionals and experts from the life sciences industry globally. It's like bringing the entire marketplace to one location. We strongly believe that SCDM, as a platform, brings us closer to our clients in understanding the challenges they face and developing innovative solutions that add value."

Acceliant eClinical Suite

Acceliant eClinical Suite is competitive in meeting the challenges of today's dynamic market conditions. The Acceliant eClinical Suite is a preeminent offering that continues its 11-year expertise in providing innovative solutions for the life sciences industry. The Acceliant eClinical Suite is robust, scalable, and flexible. It has been proven by more than 350 Phase I-IV trials, covering all therapeutic areas and medical device trials. Engineered for agility, our service model differentiators enable us to easily implement and deploy solutions in response to data, functional, and analytic needs.

Contact
Prashant Bhavaraju
CMO, Acceliant
info@acceliant.com
+1-408-387-5899


'/>"/>
SOURCE Acceliant
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. FAME 2 Published in the New England Journal of Medicine, Volcano participates in the $84M NIH-Sponsored ISCHEMIA Trial
2. PRA Participates in Landmark Alzheimers Prevention Clinical Trial
3. Misonix Participates In Cleveland Spine Review
4. BlackStratus participates in Joint FDA-ISPE CGMP Conference
5. University of Michigans Wolverine Venture Fund Participates in $25 Million Series D Investment in Sonitus Medical
6. Echo Therapeutics Announces $20 Million Financing with Platinum-Montaur Life Sciences
7. Nonin Medical Named Platinum Partner by Tri-anim Health Services
8. One-Year EVOLVE Trial Clinical Results Confirm Comparable Safety And Effectiveness Data Of The Boston Scientific SYNERGY™ Stent Versus PROMUS Element™ Platinum Chromium Stent
9. Camfil Farr to Sponsor, Participate in Premier Pharma Manufacturing Conference
10. Emergency Nurses Association Announces Corporate Sponsors for Annual Conference
11. Sae-A Trading Sponsors Medical Mission to Haiti
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/11/2017)... , July 11, 2017  Bayer has awarded grants totaling ... as part of its prestigious Bayer Hemophilia Awards Program (BHAP). ... Philadelphia and Uniformed Services University of ... among the winners. Grant recipients were announced last night during ... (ISTH) 2017 Congress, Berlin, Germany . ...
(Date:7/10/2017)... medical equipment and supply demand is forecast to reach ... Equipment & Supplies: United States , a report ... demand for medical services – driven in large part ... gains in disposable personal income – will boost sales ... also drive sales as providers and patients seek the ...
(Date:7/6/2017)... 2017 ThriveRx, the nutrition division of Diplomat Specialty Infusion Group, ... on nutrition support. To celebrate its anniversary, ThriveRx recently launched ... fresh new look with improved organization to create the best user experience ... ... "We,ve made several great ...
Breaking Medicine Technology:
(Date:7/21/2017)... ... ... The Margarian Law Firm has filed a class action lawsuit against Dr. ... ginger. Dr. Pepper produces the “Canada Dry” brand of ginger ale products. In Gegham ... Ale claims on its bottle that it is made from real ginger. , When ...
(Date:7/21/2017)... ... July 21, 2017 , ... MedMatchPlus+ has launched ... of acceptance to a residency in a United States hospital. Being accepted into ... U.S. , According to data released by the ECFMG®, every year, 50 percent ...
(Date:7/21/2017)... ... July 21, 2017 , ... West Dermatology is pleased to announce ... Beginning July 17, 2017, Ms. Vu will join West Dermatology’s large network of medical ... dermatology, skin cancer , and more. She graduated from the University of Florida ...
(Date:7/21/2017)... ... 21, 2017 , ... How physicians and athletic trainers assess ... researchers presenting their work at the American Orthopaedic Society for Sports Medicine’s ... the patterns of change in concussion symptom presentation, diagnostic tools used and length ...
(Date:7/20/2017)... ... July 20, 2017 , ... Acute myeloid leukemia (AML) ... progresses rapidly without treatment. Newly diagnosed patients face intense chemotherapy regimens and a ... relapse. With such a challenging diagnosis that requires immediate action, patients and ...
Breaking Medicine News(10 mins):